Home/Pipeline/LNTH-2507

LNTH-2507

Pancreatic Ductal Adenocarcinoma

PreclinicalActive

Key Facts

Indication
Pancreatic Ductal Adenocarcinoma
Phase
Preclinical
Status
Active
Company

About Lantheus Medical Imaging

Lantheus Medical Imaging is a leading public radiopharmaceutical company with a mission to 'Find, Fight, and Follow' disease through targeted diagnostic and therapeutic innovations. The company has achieved significant commercial success with products like PYLARIFY for prostate cancer imaging and is aggressively expanding its pipeline through strategic acquisitions and internal R&D into high-growth areas like radiotherapeutics and neurology diagnostics. Its strategy hinges on vertical integration, managing complex radiopharmaceutical logistics, and capitalizing on the growing precision medicine paradigm in nuclear medicine.

View full company profile

Other Pancreatic Ductal Adenocarcinoma Drugs

DrugCompanyPhase
CM24Purple BiotechPhase 2
ANV221AnvironPreclinical
[18F]FAPI-74 (FAPI-PRO)SofiePhase 3